Skip to main navigation ANAPTYSBIO Investor Relations ABOUT TECHNOLOGY PIPELINE INVESTORS / NEWS CAREERS CONTACT SEC FILINGS Group Filing year - Any - Items per page 10 Filing date Form Filing Group Description View Nov 17, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-065166.pdf 0001209191-21-065166.rtf 0001209191-21-065166.xls View HTML Nov 17, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-065168.pdf 0001209191-21-065168.rtf 0001209191-21-065168.xls View HTML Nov 17, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-065173.pdf 0001209191-21-065173.rtf 0001209191-21-065173.xls View HTML Nov 17, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-065178.pdf 0001209191-21-065178.rtf 0001209191-21-065178.xls View HTML Nov 15, 2021 8-K Current Reports Report of unscheduled material events or corporate event 0001370053-21-000072.pdf 0001370053-21-000072.rtf 0001370053-21-000072.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Nov 05, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-063260.pdf 0001209191-21-063260.rtf 0001209191-21-063260.xls View HTML Nov 05, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-063263.pdf 0001209191-21-063263.rtf 0001209191-21-063263.xls View HTML Nov 04, 2021 8-K Current Reports Report of unscheduled material events or corporate event 0001370053-21-000068.pdf 0001370053-21-000068.rtf 0001370053-21-000068.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Nov 04, 2021 10-Q Quarterly Filings Quarterly report which provides a continuing view of a company's financial position 0001370053-21-000069.pdf 0001370053-21-000069.rtf 0001370053-21-000069.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Nov 02, 2021 4 3,4,5 Statement of changes in beneficial ownership of securities 0001209191-21-062481.pdf 0001209191-21-062481.rtf 0001209191-21-062481.xls View HTML Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Displaying 1 - 10 of 329 results Data provided by Kaleidoscope. Tools PRINT EMAIL RSS FEEDS EMAIL ALERTS INVESTOR CONTACT DOCUMENT REQUEST ABOUT Overview Strategy Management Board of Directors Therapeutic Advisory Board TECHNOLOGY Therapeutic Antibodies Somatic Hypermutation SHM Platform Key Advantages Publications PIPELINE Overview Etokimab ANB019 Partnerships INVESTORS Overview News Events Goverance Stock Information Analyst Coverage SEC Filings FAQs Contact CAREERS Job Openings Health and Financial Benefits Overview CONTACT CONNECT LinkedIn Twitter ©20212018 ANAPTYSBIO, INC. ALL RIGHTS RESERVED. TERMS OF USE